- Home
- SMTI vs ATAI Comparison
SMTI vs ATAI Comparison
Compare SMTI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- ATAI
- Stock Information
- Founded
- SMTI 1982
- ATAI 2018
- Country
- SMTI United States
- ATAI Germany
- Employees
- SMTI N/A
- ATAI N/A
- Industry
- SMTI Medical/Dental Instruments
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- ATAI Health Care
- Exchange
- SMTI Nasdaq
- ATAI Nasdaq
- Market Cap
- SMTI 266.7M
- ATAI 282.6M
- IPO Year
- SMTI N/A
- ATAI 2021
- Fundamental
- Price
- SMTI $32.40
- ATAI $1.41
- Analyst Decision
- SMTI Strong Buy
- ATAI Strong Buy
- Analyst Count
- SMTI 2
- ATAI 3
- Target Price
- SMTI $48.50
- ATAI $10.50
- AVG Volume (30 Days)
- SMTI 20.1K
- ATAI 1.4M
- Earning Date
- SMTI 05-14-2025
- ATAI 05-19-2025
- Dividend Yield
- SMTI N/A
- ATAI N/A
- EPS Growth
- SMTI N/A
- ATAI N/A
- EPS
- SMTI N/A
- ATAI N/A
- Revenue
- SMTI $86,672,425.00
- ATAI $308,000.00
- Revenue This Year
- SMTI $23.68
- ATAI $65.58
- Revenue Next Year
- SMTI $5.80
- ATAI N/A
- P/E Ratio
- SMTI N/A
- ATAI N/A
- Revenue Growth
- SMTI 33.36
- ATAI N/A
- 52 Week Low
- SMTI $25.86
- ATAI $1.03
- 52 Week High
- SMTI $39.08
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- SMTI 56.59
- ATAI 44.57
- Support Level
- SMTI $30.54
- ATAI $1.36
- Resistance Level
- SMTI $33.14
- ATAI $1.54
- Average True Range (ATR)
- SMTI 1.07
- ATAI 0.09
- MACD
- SMTI 0.24
- ATAI -0.00
- Stochastic Oscillator
- SMTI 85.11
- ATAI 0.00
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.